nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessment of treatment outcomes in patients with overactive bladder: Importance of objective and subjective measures
|
Abrams, Paul |
|
2006 |
1-20 |
2S |
p. 17-28 12 p. |
artikel |
2 |
Behavioral intervention for community-dwelling individuals with urinary incontinence
|
Fantl, J.A. |
|
1998 |
1-20 |
2S |
p. 30-34 5 p. |
artikel |
3 |
Behavioral modification for institutionalized individuals with urinary incontinence
|
O'Donnell, Pat D. |
|
1998 |
1-20 |
2S |
p. 40-42 3 p. |
artikel |
4 |
Biofeedback for community-dwelling individuals with urinary incontinence
|
Payne, Christopher K. |
|
1998 |
1-20 |
2S |
p. 35-39 5 p. |
artikel |
5 |
Castration plus nilutamide vs castration plus placebo in advanced prostate cancer
|
Du Plessis, Dionisius J. |
|
1991 |
1-20 |
2S |
p. 20-24 5 p. |
artikel |
6 |
Combination of anandron with orchiectomy in treatment of metastatic prostate cancer
|
Beland, Gilles |
|
1991 |
1-20 |
2S |
p. 25-29 5 p. |
artikel |
7 |
Development and validation of patient-reported outcomes measures for overactive bladder: A review of concepts
|
Coyne, Karin S. |
|
2006 |
1-20 |
2S |
p. 9-16 8 p. |
artikel |
8 |
Developments in the Pathology of Penile Squamous Cell Carcinomas
|
Chaux, Alcides |
|
2010 |
1-20 |
2S |
p. S7-S14 8 p. |
artikel |
9 |
Diagnosis and Staging of Penile Cancer
|
Heyns, Chris F. |
|
2010 |
1-20 |
2S |
p. S15-S23 9 p. |
artikel |
10 |
Early versus late hormonal therapy: debating the issues
|
Crawford, E.David |
|
2003 |
1-20 |
2S |
p. 8-13 6 p. |
artikel |
11 |
Electrical stimulation for the treatment of urinary incontinence
|
Appell, Rodney A. |
|
1998 |
1-20 |
2S |
p. 24-26 3 p. |
artikel |
12 |
Eligard: leuprolide acetate in a novel sustained-release delivery system
|
Sartor, Oliver |
|
2003 |
1-20 |
2S |
p. 25-31 7 p. |
artikel |
13 |
Epidemiology and Natural History of Penile Cancer
|
Pow-Sang, Mariela R. |
|
2010 |
1-20 |
2S |
p. S2-S6 5 p. |
artikel |
14 |
Epidemiology, pathophysiology, and evaluation of urinary incontinence and overactive bladder
|
Payne, Christopher K. |
|
1998 |
1-20 |
2S |
p. 3-10 8 p. |
artikel |
15 |
Hormonal therapy: historical perspective to future directions
|
Mcleod, David G. |
|
2003 |
1-20 |
2S |
p. 3-7 5 p. |
artikel |
16 |
Introduction
|
Mcleod, David G. |
|
2003 |
1-20 |
2S |
p. 1-2 2 p. |
artikel |
17 |
Introduction
|
Brubaker, Linda |
|
2006 |
1-20 |
2S |
p. 1-2 2 p. |
artikel |
18 |
Introduction
|
Debruyne, Frans M.J. |
|
1991 |
1-20 |
2S |
p. 3-4 2 p. |
artikel |
19 |
Introduction: Urinary incontinence: The scope of the problem—the solutions on the horizon
|
Wein, Alan J. |
|
1998 |
1-20 |
2S |
p. 1-2 2 p. |
artikel |
20 |
Management of the Lymph Nodes in Penile Cancer
|
Heyns, Chris F. |
|
2010 |
1-20 |
2S |
p. S43-S57 15 p. |
artikel |
21 |
National Comprehensive Cancer Network guidelines for the management of prostate cancer
|
Scherr, Douglas |
|
2003 |
1-20 |
2S |
p. 14-24 11 p. |
artikel |
22 |
New Developments in the Treatment of Localized Penile Cancer
|
Solsona, Eduardo |
|
2010 |
1-20 |
2S |
p. S36-S42 7 p. |
artikel |
23 |
Outcome measures for urinary incontinence
|
Blaivas, Jerry G. |
|
1998 |
1-20 |
2S |
p. 11-19 9 p. |
artikel |
24 |
Patient-reported outcomes in overactive bladder: Importance for determining clinical effectiveness of treatment
|
Brubaker, Linda |
|
2006 |
1-20 |
2S |
p. 3-8 6 p. |
artikel |
25 |
Patient-reported outcomes in overactive bladder: The influence of perception of condition and expectation for treatment benefit
|
Marschall-Kehrel, Daniela |
|
2006 |
1-20 |
2S |
p. 29-37 9 p. |
artikel |
26 |
Penile Cancer—Prevention and Premalignant Conditions
|
Minhas, Suks |
|
2010 |
1-20 |
2S |
p. S24-S35 12 p. |
artikel |
27 |
Penile Cancer—Update
|
Pompeo, Antonio Carlos Lima |
|
2010 |
1-20 |
2S |
p. S1- 1 p. |
artikel |
28 |
Pharmacokinetics and metabolismof nilutamide
|
Creaven, Patrick J. |
|
1991 |
1-20 |
2S |
p. 13-19 7 p. |
artikel |
29 |
Pharmacologic options for the overactive bladder
|
Wein, Alan J. |
|
1998 |
1-20 |
2S |
p. 43-47 5 p. |
artikel |
30 |
Pharmacology of antiandrogens and valueof combining androgen suppression with antiandrogen therapy
|
Gaillard-Moguilewsky, Martine |
|
1991 |
1-20 |
2S |
p. 5-12 8 p. |
artikel |
31 |
Prognostic Factors in Penile Cancer
|
Ficarra, Vincenzo |
|
2010 |
1-20 |
2S |
p. S66-S73 8 p. |
artikel |
32 |
Round table discussion
|
|
|
1991 |
1-20 |
2S |
p. 30-32 3 p. |
artikel |
33 |
Side effects of androgen deprivation therapy: monitoring and minimizing toxicity
|
Higano, Celestia S |
|
2003 |
1-20 |
2S |
p. 32-38 7 p. |
artikel |
34 |
Special considerations in elderly individuals with urinary incontinence
|
O'Donnell, Pat D. |
|
1998 |
1-20 |
2S |
p. 20-23 4 p. |
artikel |
35 |
Surgery for the treatment of overactive bladder
|
Appell, Rodney A. |
|
1998 |
1-20 |
2S |
p. 27-29 3 p. |
artikel |
36 |
The effects of antimuscarinics on health-related quality of life in overactive bladder: A systematic review and meta-analysis
|
Khullar, Vik |
|
2006 |
1-20 |
2S |
p. 38-48 11 p. |
artikel |
37 |
Title Page
|
|
|
2010 |
1-20 |
2S |
p. A1- 1 p. |
artikel |
38 |
Treatment of Visceral, Unresectable, or Bulky/Unresectable Regional Metastases of Penile Cancer
|
Pettaway, Curtis A. |
|
2010 |
1-20 |
2S |
p. S58-S65 8 p. |
artikel |